The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase 1/2a study of BAL101553, a novel tumor checkpoint controller (TCC), administered as 48-hour infusion in adult patients with advanced solid tumors.
 
Markus Joerger
Research Funding - Basilea (Inst)
 
Ioannis Metaxas
No Relationships to Disclose
 
Anastasios Stathis
No Relationships to Disclose
 
Dagmar Hess
No Relationships to Disclose
 
Michael Thomas Mark
No Relationships to Disclose
 
Franziska Hutter
No Relationships to Disclose
 
Nicole Levy
No Relationships to Disclose
 
Silvia Stuedeli
No Relationships to Disclose
 
Simona Berardi
No Relationships to Disclose
 
Michèle Landau-Salzberg
Employment - Landau Consulting Services
 
Marc Frederick Engelhardt
Employment - Basilea
Stock and Other Ownership Interests - Basilea
 
Patrice Larger
Employment - Basilea
Stock and Other Ownership Interests - Basilea
 
Thomas Kaindl
Employment - Basilea; Novartis (I)
Stock and Other Ownership Interests - Basilea
 
Peter Hafner
No Relationships to Disclose
 
Phil McKernan
Employment - Basilea
Stock and Other Ownership Interests - Basilea
 
Heidi A Lane
Employment - Basilea
Stock and Other Ownership Interests - Basilea
Research Funding - Basilea
Patents, Royalties, Other Intellectual Property - Basilea
 
Roger Anton Fredy Von Moos
Honoraria - Bayer/Onyx; Roche
Consulting or Advisory Role - Amgen (Inst); Bayer/Onyx (Inst); Bristol-Myers Squibb (Inst); Merck Serono (Inst); Merck Sharp & Dohme (Inst); Novartis (Inst); Roche/Genentech (Inst)
Research Funding - Bayer/Onyx (Inst); Merck Serono (Inst)
Other Relationship - Pfizer
 
Cristiana Sessa
Research Funding - Basilea (Inst)